Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
NCT00004278Phase 3Completed
- Sponsor
- National Center for Research Resources
- Start
- Dec 1991
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised, open-label trial of ganciclovir in cytomegalovirus infection (CMV) (2 arms), sponsored by National Center for Research Resources. Started Dec 1991; status: completed.
02
Drugs
ganciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00004278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004278.